About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Gland Pharma Ltd.
BSE Code
543245
ISIN Demat
INE068V01023
Book Value
610.02
NSE Code
GLAND
Dividend Yield %
1.09
Market Cap
273092.01
P/E
23.62
EPS
70.19
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
23-Dec-2025
1678.10
1695.70
1672.05
1686.00
1974
3322922
22-Dec-2025
1680.60
1691.75
1675.10
1689.70
2671
4500330
19-Dec-2025
1664.40
1695.50
1657.65
1671.05
8590
14373129
18-Dec-2025
1650.00
1669.10
1632.60
1665.90
2863
4723383
17-Dec-2025
1663.90
1671.55
1650.65
1654.15
1070
1778963
16-Dec-2025
1667.00
1684.00
1662.00
1663.90
2166
3623908
15-Dec-2025
1673.05
1687.35
1655.45
1669.90
2298
3829898
12-Dec-2025
1686.05
1719.90
1675.00
1679.75
3332
5644243
11-Dec-2025
1707.60
1707.65
1667.20
1692.85
3557
5993178
10-Dec-2025
1698.25
1716.90
1695.85
1711.35
24081
41176231
09-Dec-2025
1689.05
1719.85
1676.90
1712.10
3476
5933085
08-Dec-2025
1750.55
1750.55
1686.00
1703.00
1568
2692217
05-Dec-2025
1726.85
1758.25
1720.00
1750.55
3831
6697376
04-Dec-2025
1814.45
1814.45
1714.05
1730.85
5128
8904822
03-Dec-2025
1766.65
1814.15
1747.65
1769.80
8752
15635536
02-Dec-2025
1710.25
1790.50
1710.25
1767.60
15565
27530149
01-Dec-2025
1760.00
1765.40
1725.00
1726.20
2228
3883398
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.